3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
9
Wilms Tumor
2
Pancreatic Neoplasms
2
Kidney Neoplasms
2
Urogenital Neoplasms
1
Thyroid Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Neoplastic Syndromes, Hereditary
1
Neoplasm Metastasis
1
Hepatic Veno-Occlusive Disease
1
Genetic Predisposition to Disease
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
fludarabine phosphate
7
Mycophenolic Acid
7
Peripheral Blood Stem Cell Transplantation
6
Flow Cytometry
6
Cyclophosphamide
6
Whole-Body Irradiation
5
Therapeutics
5
Cyclosporine
5
Polymerase Chain Reaction
4
Methylprednisolone
4
Antilymphocyte Serum
4
Vorinostat
3
Tacrolimus
3
Radiotherapy
3
Psychiatric Rehabilitation
3
Methotrexate
3
Immunoenzyme Techniques
3
Filgrastim
3
Doxorubicin
3
Caspofungin
3
Busulfan
3
Alemtuzumab
3
thymoglobulin
2
liposomal amphotericin B
2
aflibercept
2
Voriconazole
2
Sunitinib
2
Prednisone
2
Ondansetron
2
Itraconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Genetic Testing
×
Genitourinary
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled